Purchase Order N3239820P0322
Award Date 5/18/20
Potential Completion Date 6/5/20
Potential Value $97K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $97,000 firm fixed-price purchase order contract awarded by the Medical Command of the U.S. Department of Defense to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the MAGNA PURE 96 SYSTEM, with a completion date of December 11, 2020. This contract was awarded without a set-aside designation and is part of the federal government's National Interest...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the delivery of MAGNA PURE 96 INSTRUMENTS. The contract, which has a potential value of $180,000.00, does not have a set-aside designation and has an anticipated completion date of April 15, 2022. Roche Diagnostics, a foreign-owned, for-profit manufacturer of in vitro diagnostics,...
- The Department of the Army Medical Command awarded a firm-fixed-price purchase order contract to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments, to provide a MAGNA PURE 96 INSTRUMENT IVD. The contract has a potential value of $194,000.00 and a completion date of January 11, 2021. This award was made through a special notice solicitation using simplified acquisition procedures and was not set aside for any...
- This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the MAGNA PURE 96 INSTRUMENT IVD, with a ceiling value of $90,000.00 and a completion date of July 15, 2017. Roche Diagnostics has received numerous federal contract awards, including through its...
- This is a $109,000.00 firm fixed price purchase order awarded by the Air Education and Training Command, a component of the U.S. Department of Defense, to Roche Diagnostics Corporation for the MAGNA PURE 96 INSTRUMENT. The award did not utilize a set-aside program. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services, and has received numerous federal contract awards to supply medical equipment and...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Roche Diagnostics Corporation for the MAGNA PURE 96 IVD INSTRUMENT. The contract has a ceiling value of $105,000.00 and an ultimate completion date of March 21, 2016. The contract is not designated as a set-aside. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the MAGNA PURE96 INSTRUMENT. The contract has a ceiling value of $91,563.00 and an ultimate completion date of August 31, 2017. The contract is not designated as a set-aside. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to...
- This federal contract award, with an ID of HHSD2002017M93189P, was made by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for the procurement of a MAGNA PURE 96 INSTRUMENT WITH ACCESSORIES. The fixed-price contract has a ceiling value of $105,000.00 and an ultimate completion date of March 30, 2017. Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory...
- The Department of the Army Medical Command awarded a $126,906.56 firm fixed price purchase order contract to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for the supply of the MAGNA PURE 96 INSTRUMENT IVD and associated reagents, supplies, consumables, and maintenance. This sole source award was issued under the authority of 41 U.S.C. 1901 due to the urgency of the requirement or the availability of only one reasonably qualified source. The award was not set aside...
- This federal contract award is for the MAGNA PURE 96 SYSTEM, a purchase order valued at $97,000.00 awarded to the prime contractor Roche Diagnostics Corporation by the U.S. Army Medical Command (MEDCOM). The contract has a completion date of September 22, 2021 and was awarded on September 14, 2021. This purchase order was not set aside for any specific business category. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and...